Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist.

× No keyword cloud information.

5 in total

Review 1. The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction: JACC State-of-the-Art Review.

Authors: Jonathan D Newman; Anish K Vani; Jose O Aleman; Howard S Weintraub; Jeffrey S Berger; Arthur Z Schwartzbard
Journal: J Am Coll Cardiol Date: 2018-10-09 Impact factor: 24.094

Review 2. Effect of ertugliflozin on glycemic levels, blood pressure and body weight of patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors: Maryam Zaman; Roha Saeed Memon; Arooba Amjad; Tehlil Rizwan; Jai Kumar; Ibtehaj Ul Haque; Syed Saad Ali; Lin Li; Muhammad Shariq Usman
Journal: J Diabetes Metab Disord Date: 2020-09-03

3. The sodium-glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats.

Authors: Hsiang-Chun Lee; Yi-Lin Shiou; Shih-Jie Jhuo; Chia-Yuan Chang; Po-Len Liu; Wun-Jyun Jhuang; Zen-Kong Dai; Wei-Yu Chen; Yun-Fang Chen; An-Sheng Lee
Journal: Cardiovasc Diabetol Date: 2019-04-01 Impact factor: 9.951

Review 4. Mechanisms and Perspectives of Sodium-Glucose Co-transporter 2 Inhibitors in Heart Failure.

Authors: Qingchun Zeng; Qing Zhou; Weitao Liu; Yutong Wang; Xingbo Xu; Dingli Xu
Journal: Front Cardiovasc Med Date: 2021-02-10

Review 5. Evolution of Type 2 Diabetes Management from a Glucocentric Approach to Cardio-Renal Risk Reduction: The New Paradigm of Care.

Authors: Stephan Jacob; Andrew J Krentz; John Deanfield; Lars Rydén
Journal: Drugs Date: 2021-07-24 Impact factor: 9.546

5 in total